Results 191 to 200 of about 272,684 (347)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

Arthritis & Rheumatology, 2016
L. Coates, A. Kavanaugh, P. Mease, E. Soriano, Maria Laura Acosta-Felquer, A. Armstrong, W. Bautista-Molano, W. Boehncke, Willemina Campbell, A. Cauli, L. Espinoza, O. FitzGerald, D. Gladman, A. Gottlieb, P. Helliwell, M. Husni, T. Love, E. Lubrano, N. McHugh, P. Nash, A. Ogdie, A. Orbai, Andrew Parkinson, D. O'Sullivan, C. Rosen, S. Schwartzman, E. Siegel, S. Toloza, William Tuong, C. Ritchlin   +29 more
semanticscholar   +1 more source

Psoriasis Treated by Riboflavin

, 1952
Merlin T-R. Maynard
openalex   +1 more source

THE TREATMENT OF PSORIASIS BY PYROGALLIC ACID. [PDF]

, 1881
Geoege Thin
openalex   +1 more source

Erythematous Papules and Plaques in an Infant Receiving Glucagon Therapy

JEADV Clinical Practice, EarlyView.
Sara Al Janahi, Alya Al‐Ali, Meera Al Adawi, Yusra S. Al Ali, Harish Bangalore   +4 more
wiley   +1 more source

Patient Perspectives on the Impact of Living With Hidradenitis Suppurativa: Results From the Global ‘HS Uncovered’ Burden of Disease Survey

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, painful inflammatory skin disease. There is a need to evaluate how patients experience their disease. Objectives The HS Uncovered survey was conducted to understand patient activation, the patient journey and burden of disease.
Georgios Kokolakis, Eva Vilarrasa, Amit Garg, Ivette Alarcon, Mei Go, Gillian Newbold, Aikaterini Mamareli, Craig Richardson, Barry M. McGrath, Philippe Guillem   +9 more
wiley   +1 more source

All-cause and cause-specific mortality in psoriasis patients: a systematic review and meta-analysis. [PDF]

Front Immunol
Yang Y, Zhang Q, Huang A, Zhao J, Yang J, Wang L, Xu G.   +6 more
europepmc   +1 more source

Association Between Psoriasis and COVID‐19 in the 2023 National Health Interview Survey

JEADV Clinical Practice, EarlyView.
Priya Engel, Caitlyn Kellogg, Sogol Stephanie Javadi, Jan Smogorzewski   +3 more
wiley   +1 more source

The Impact of Methotrexate on Cardiovascular Outcomes in Psoriasis: A Systematic Review and Meta‐Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic immune‐mediated inflammatory disease with a global prevalence of 2%–3% and 1.3% in Brazil. It is associated with comorbidities such as obesity, hypertension, and diabetes, all of which contribute to increased cardiovascular risk due to systemic inflammation and endothelial dysfunction.
Tiago A. S. Costa, Sheila T. K. Medorima, Renata F. Magalhães   +2 more
wiley   +1 more source

IL-17A inhibitors modulate skin microbiome in psoriasis: implications for microbial homeostasis. [PDF]

J Transl Med
Lv Y, Bian H, Jing Y, Zhou J.
europepmc   +1 more source

Psoriasis and comorbid diseases: Epidemiology.

Journal of American Academy of Dermatology, 2017
J. Takeshita, S. Grewal, S. Langan, N. Mehta, A. Ogdie, A. V. Van Voorhees, J. Gelfand   +6 more
semanticscholar   +1 more source